A molecule that may offer a target for treatment of mental impairment in people with Down syndrome has been identified by scientists at the Institute of Psychiatry at King's College London, England.
Advertisement
They found that people with Down syndrome have higher levels of the molecule myo-inositol in their brains than healthy people, and that higher levels of the molecule are associated with lower levels of intellectual ability, BBC News reported.
The study authors said they also suspect that high levels of the molecule may predispose people with Down syndrome to early-onset Alzheimer's disease. It's already known that myo-inositol promotes formation of amyloid plaques associated with Alzheimer's disease.
The findings appear in the journal Archives of General Psychiatry. – (HealthDayNews)
Bookmark with:
What are social bookmarks?